Cardiomyopathy: Understanding Heart Muscle Disease
Cardiomyopathy is disease of the heart muscle itself. The heart becomes enlarged, thick, or rigid, leading to weakened pumping and potential heart failure. Multiple types exist, each with different causes and treatments.
ICD Code: I42.9
Understanding Cardiomyopathy
Cardiomyopathy refers to diseases of the heart muscle where the muscle itself is abnormal—unlike coronary artery disease where the muscle is starved of blood, or valve disease where the valves are damaged. In cardiomyopathy, the muscle is intrinsically diseased, leading to weakened pumping, abnormal filling, or both. Cardiomyopathy affects approximately 1 in 250-500 adults, with up to 50% of cases having a genetic component.Hershberger et al. JACC, 2022
Think of your heart muscle like any other muscle. It should be flexible and strong. In cardiomyopathy, it becomes thick and stiff (can't fill properly) or thin and weak (can't pump properly). Either way, the heart can't do its job effectively.
Not All Cardiomyopathy is the Same
The three main types have very different causes and treatments:
- Dilated (DCM): Heart becomes enlarged and weak2022 AHA/ACC/HFSA Guideline
- Hypertrophic (HCM): Heart muscle becomes abnormally thickMaron et al. NEJM, 2021
- Restrictive (RCM): Heart muscle becomes rigid
Treatment and prognosis vary dramatically by type. Accurate classification is crucial.
Types of Cardiomyopathy
Recognizing Cardiomyopathy Symptoms
Cardiomyopathy Symptoms
Symptoms vary by type but often overlap with heart failure
Shortness of breath, especially with exertion or when lying flat
The heart can't pump efficiently (DCM) or can't fill properly (HCM/RCM). Either way, blood backs up into lungs causing breathing difficulty. This is often the first symptom people notice.
Fatigue and weakness, can't do what you used to do
Reduced cardiac output means muscles don't get adequate blood flow. You tire easily and may feel like you're "out of shape" when there's actually a medical problem.
Swelling in legs, ankles, feet, or abdomen
Fluid retention results from poor circulation. Blood backs up in the body, causing edema. Abdominal swelling (ascites) can occur with right-sided failure.
Palpitations, skipped beats, or rapid heart rate
Cardiomyopathy increases risk of arrhythmias. Atrial fibrillation is common. HCM specifically increases risk of dangerous ventricular arrhythmias.
Chest pain or pressure, especially with exertion
The thickened heart muscle of HCM needs more oxygen than supply can provide. This causes angina-like chest pain even with normal coronary arteries.
Fainting or near-fainting, especially during exercise
Particularly concerning with HCM. Thickened muscle can obstruct blood flow out of the heart, causing drop in blood pressure and fainting. This is a red flag symptom requiring urgent evaluation.
When to Seek Emergency Care
Go to ER or call 911 for:
- Fainting or loss of consciousness (especially during exercise)
- Severe shortness of breath (can't speak in full sentences)
- Chest pain (could indicate ischemia or other emergency)
- Rapid or irregular heartbeat with dizziness
Fainting during exercise is particularly concerning for HCM and requires immediate cardiac evaluation.
Causes and Risk Factors
What Causes Cardiomyopathy?
| Factor | Effect | What to Do |
|---|
Always tell your doctor about medications, supplements, and recent health events before testing.
Diagnosis and Evaluation
Diagnostic Tests for Cardiomyopathy
- Echocardiogram: Most important test—shows heart size, wall thickness, pumping function
- ECG: Shows electrical changes, arrhythmias, patterns suggesting specific types
- Cardiac MRI: Detailed images of heart muscle, can detect scarring and specific causes
- Stress test: Evaluates symptoms with exertion, checks for obstruction in HCM
- Genetic testing: Identifies mutations, guides family screening
- Cardiac catheterization: Checks coronary arteries (rules out CAD as cause)
- Blood tests: Iron studies, autoimmune markers, viral titers looking for specific causes
Treatment by Type
Dilated Cardiomyopathy (DCM)
Goal: Improve pumping function, prevent progression, treat heart failure
- Medications: ACE inhibitors/ARBs/ARNI, beta-blockers, aldosterone antagonists, SGLT2 inhibitors
- Devices: ICD for sudden death prevention, CRT for dyssynchrony
- Advanced therapies: LVAD (left ventricular assist device), heart transplant
Hypertrophic Cardiomyopathy (HCM)
Goal: Relieve obstruction, control symptoms, prevent sudden death
- Beta-blockers or calcium channel blockers: Relieve obstruction, improve symptoms
- Septal reduction therapy: Alcohol septal ablation or surgical myectomy for obstruction
- ICD: For sudden death prevention in high-risk patients
- Activity restriction: Competitive sports may be restricted depending on risk
Restrictive Cardiomyopathy (RCM)
Goal: Manage symptoms, treat underlying cause
- Diuretics: For fluid overload
- Treat underlying condition: Chemotherapy for amyloidosis, phlebotomy for hemochromatosis
- Heart transplant: Often needed as disease progresses
Family Screening
Since many cardiomyopathies are genetic:
- First-degree relatives (parents, siblings, children) should be screened
- Screening includes: Echocardiogram, ECG, possibly genetic testing
- Frequency: Every 1-5 years depending on specific situation
- Importance: Early detection allows treatment before complications develop
Living with Cardiomyopathy
Lifestyle Recommendations
- Take medications faithfully: They improve survival and symptoms
- Regular follow-up: Cardiology visits every 3-6 months minimum
- Sodium restriction: < 2,000 mg daily (less fluid retention)
- Exercise: As approved by cardiologist (avoid intense exercise if high-risk)
- Avoid alcohol: Especially if alcoholic cardiomyopathy diagnosed
- Report symptoms: Worsening symptoms need prompt evaluation
- Emotional health: Depression is common—seek support if needed
Related Conditions
- Heart Failure: End result of untreated cardiomyopathy
- Atrial Fibrillation: Common complication
- Sudden Cardiac Arrest: Risk in HCM and DCM with poor EF
FAQ
References
References
- [1]2022 AHA/ACC/HFSA Guideline for the Management of Cardiomyopathy. Circulation. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
- [2]2020 ESC Guidelines on the Classification and Diagnosis of Cardiomyopathies. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaa461
- [3]Hershberger R et al. Genetic Evaluation of Cardiomyopathy. Journal of the American College of Cardiology, 2022. https://www.jacc.org/doi/10.1016/j.jacc.2022.01.010
- [4]Maron BJ et al. Hypertrophic Cardiomyopathy. New England Journal of Medicine, 2021. https://doi.org/10.1056/NEJMra2108465
- [5]Gilliam CH et al. Genetic Testing in Hypertrophic Cardiomyopathy. Circulation, 2023. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.062345
- [6]Olivotto I et al. Hypertrophic Cardiomyopathy Management. Lancet, 2022. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)00514-3
- [7]Mayo Clinic. Cardiomyopathy Evaluation and Treatment. https://www.mayoclinic.org/diseases-conditions/cardiomyopathy/diagnosis-treatment/drc-20353573
- [8]American Heart Association. Cardiomyopathy Statistics - 2024 Update. https://www.heart.org/en/health-topics/cardiomyopathy
- [9]NIH. Genetic Cardiomyopathy Research. https://www.nhlbi.nih.gov/science/genetic-cardiomyopathy
- [10]HRS/EHRA Expert Consensus on Genetics of Cardiomyopathy. https://www.hrsonline.org/
Need a monitoring plan?
Track your labs, vitals, and symptoms in one dashboard with reminders.